Europe Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country- Product Image

Sale

Europe Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country

Report
155 Pages
November 2020
Region: Europe
The Insight Partners
ID: 5231468

UP TO €1448EUR$1,500USD£1,242GBP OFF until Jun 30^th 2024

According to the publisher's new market research study on “Europe Gastrointestinal Drugs Market to 2027 - Regional Analysis and Forecast - by Drug Class, Route of Administration, Application, and Distribution Channel” the market is expected to reach US$ 17,810.81 million by 2027 from US$ 12,721.85 million in 2019; it is estimated to grow at a CAGR of 4.4% from 2020 to 2027. The report provides trends prevailing in the Europe gastrointestinal drugs market and the factors driving the market growth along with those hindering it.

In 2019, the acid neutralizers segment accounted for the highest share of the market. However, the biologics segment is expected to be the fastest-growing during the forecast period. The CAGR of the biologics segment accounted the highest CAGR in the forecast period. The growth of the segment is attributed to growing product development and increasing product launches in the market.

The growth of the Europe Gastrointestinal Drugs market is mainly attributed to rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics. However, side effects associated with the drugs will restrict the market growth.

Sanofi; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; AstraZeneca; and Bayer AG are among the leading companies operating in the Europe Gastrointestinal Drugs market.

The Report Segments Europe Gastrointestinal Drugs Market as Follows:

Europe Gastrointestinal Drugs Market - By Drug Class

Acid Neutralizers
Antidiarrheal and Laxatives
Anti-Inflammatory Drugs
Antiemetic and Antinauseants
Biologics
Others

Europe Gastrointestinal Drugs Market - By Route of Administration

Oral
Parenteral

Europe Gastrointestinal Drugs Market - By Application

Inflammatory Ulcerative Colitis
Crohn's Disease
Irritable Bowel Syndrome
Gastroenteritis
Celiac Disease
Others

Europe Gastrointestinal Drugs Market - By Country

Europe
Germany
UK
France
Italy
Spain
Rest of Europe

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe gastrointestinal drugs market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Gastrointestinal Drugs Market - by Drug Class
1.3.2 Europe Gastrointestinal Drugs Market - by Route of Administration
1.3.3 Europe Gastrointestinal Drugs Market - by Application
1.3.4 Europe Gastrointestinal drugs Market - by Distribution Channel
1.3.5 Europe Gastrointestinal drugs Market - by Country

2. Europe Gastrointestinal Drugs Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Gastrointestinal Drugs Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.2.1 Gastrointestinal Drugs Market - Europe PEST Analysis
4.3 Expert Opinion

5. Europe Gastrointestinal Drugs Market - Key Market Dynamics

5.1 Key Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
5.1.2 Increase in Development of Biologics
5.2 Market Restraints
5.2.1 Side Effects Associated With The Drugs
5.3 Market Opportunities
5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
5.4 Future Trends
5.4.1 Emergence of Biosimilars
5.5 Impact Analysis

6. Gastrointestinal Drugs Market - Europe Analysis

6.1 Europe Gastrointestinal Drugs Market Revenue Forecasts and Analysis

7. Europe Gastrointestinal Drugs Market Analysis and Forecasts to 2027 - by Drug Class

7.1 Overview
7.2 Europe Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
7.2.1 Europe Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 Europe Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Antidiarrheal and Laxatives
7.4.1 Overview
7.4.2 Europe Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Anti-Inflammatory Drugs
7.5.1 Overview
7.5.2 Europe Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Antiemetic and Antinauseants
7.6.1 Overview
7.6.2 Europe Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Biologics
7.7.1 Overview
7.7.2 Europe Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Others
7.8.1 Overview
7.8.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Europe Gastrointestinal Drugs Market Analysis - by Route of Administration

8.1 Overview
8.2 Europe Gastrointestinal Drugs Market, by Route of Administration 2019-2027 (%)
8.2.1 Europe Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
8.3 Oral
8.3.1 Overview
8.3.2 Europe Oral Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Parenteral
8.4.1 Overview
8.4.2 Europe Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Gastrointestinal Drugs Market Analysis - by Application

9.1 Overview
9.2 Europe Gastrointestinal Drugs Market, by Application 2019-2027 (%)
9.2.1 Europe Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
9.3 Inflammatory Ulcerative Colitis
9.3.1 Overview
9.3.2 Europe Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Crohn's Disease
9.4.1 Overview
9.4.2 Europe Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Irritable Bowel Syndrome
9.5.1 Overview
9.5.2 Europe Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Gastroenteritis
9.6.1 Overview
9.6.2 Europe Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Celiac Disease
9.7.1 Overview
9.7.2 Europe Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Europe Gastrointestinal Drugs Market Analysis - by Distribution Channel

10.1 Overview
10.2 Europe Gastrointestinal Drugs Market, by Distribution Channel 2019-2027 (%)
10.2.1 Europe Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Europe Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Europe Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Online Pharmacies
10.5.1 Overview
10.5.2 Europe Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

11. Gastrointestinal Drugs Market Revenue and Forecasts to 2027 - Geographical Analysis

11.1 Europe Gastrointestinal Drugs Market Revenue and Forecasts to 2027
11.1.1 Overview
11.1.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.4 Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.5 Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.6 Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.7 Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
11.1.8 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Germany: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.8.3 Germany: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.8.4 Germany: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.8.5 Germany: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.9 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 UK: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.9.3 UK: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.9.4 UK: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.9.5 UK: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.10 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 France: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.10.3 France: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.10.4 France: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.10.5 France: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.11 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.1 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.2 Spain: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.11.3 Spain: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.11.4 Spain: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.11.5 Spain: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.12 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Italy: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.12.3 Italy: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.12.4 Italy: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.12.5 Italy: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.13 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.13.1 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.13.2 Rest of Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.13.3 Rest of Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.13.4 Rest of Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.13.5 Rest of Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)

12. Impact of COVID-19 Pandemic on Europe Gastrointestinal Drugs Market

12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. Company Profiles

13.1 Sanofi
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 AstraZeneca
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bayer AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 Glossary of Terms

List of Tables

Table 1. Europe Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
Table 2. Europe Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
Table 3. Europe Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 4. Europe Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
Table 5. Europe Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 6. Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. Europe Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 8. Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Germany Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. Germany Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Germany Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Germany Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. UK Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 14. UK Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. UK Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 16. UK Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. France Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 18. France Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. France Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. France Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Spain Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 22. Spain Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 23. Spain Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 24. Spain Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. Italy Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 26. Italy Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 27. Italy Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. Rest of Europe Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 30. Rest of Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 31. Rest of Europe Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 32. Rest of Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 33. Glossary of Terms, Gastrointestinal Drugs Market

List of Figures

Figure 1. Gastrointestinal Drugs Market Segmentation
Figure 2. Europe Gastrointestinal Drugs Market Overview
Figure 3. Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market
Figure 4. UK is Expected to show Remarkable Growth during the Forecast Period
Figure 5. Europe Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)
Figure 6. Gastrointestinal Drugs Market - Europe PEST Analysis
Figure 7. Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint
Figure 8. Europe Gastrointestinal Drugs market - Revenue Forecasts and Analysis-2019-2027
Figure 9. Europe Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
Figure 10. Europe Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Europe Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Europe Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Europe Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Europe Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)
Figure 17. Europe Oral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Europe Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)
Figure 20. Europe Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Europe Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Europe Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)
Figure 27. Europe Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Europe Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Europe Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Europe: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. Europe Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
Figure 33. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in European Countries

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Sanofi
GlaxoSmithKline plc
Johnson and Johnson Services, Inc.
AstraZeneca
Bayer AG

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2027EUR$2,100USD£1,739GBP €2896EUR$3,000USD£2,484GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2703EUR$2,800USD£2,318GBP €3861EUR$4,000USD£3,312GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3378EUR$3,500USD£2,898GBP €4826EUR$5,000USD£4,140GBP

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Gastrointestinal Therapeutics - Global Strategic Business Report

Global Gastrointestinal Drugs Market by Drug Category (Acid Neutralizers, Anti-Inflammatory, Antiemetic & Antinauseants), Disease Type (Gastroesophageal Reflux Disorder, Irritable Bowel Syndrome), Route of Administration, End User - Forecast 2024-2030

Global Gastrointestinal Diseases Therapeutics Market 2023-2027

Global Gastrointestinal OTC Drugs Market 2023-2027

Global Gastrointestinal Drugs Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis